Ultromics obtains FDA clearance for Cardiac Amyloidosis screening device

Ultromics’ EchoGo Amyloidosis, clinical AI for echocardiography with the potential to revolutionise early detection of Cardiac Amyloidosis according to the company, has received US Food and Drug Administration (FDA) clearance.